HIV/AIDS: A minority health issue

被引:91
作者
Cargill, VA
Stone, VE
机构
[1] NIH, Off AIDS Res, Bethesda, MD 20892 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
[3] Massachusetts Gen Hosp, Gen Med Unit, Boston, MA 02114 USA
关键词
D O I
10.1016/j.mcna.2005.03.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
HIV infection disproportionately affects racial and ethnic minority populations in the United States. The reasons for this disproportionate impact are complex, and intertwined with many confounding issues that also disproportionately affect racial and ethnic minorities. Superimposed on these factors are the unique cultural beliefs and contexts that influence behavior, health beliefs in general, and HIV infection in particular. As the epidemic continues in these communities, presentations of plicated by the presence of other chronic portionate in these communities, Failure broad-based prevention interventions for ties virtually ensures that HIV transmission in communities already severely affected. HIV infection are diseases that are disproportionate to achieve successful racial and ethnic minorities virtually ensures that HIV transmission will continue unabated in communities already severely affected.
引用
收藏
页码:895 / +
页数:20
相关论文
共 70 条
[1]   Management of psychiatric disorders in patients infected with human immunodeficiency virus [J].
Angelino, AF ;
Treisman, GJ .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (06) :847-856
[2]  
[Anonymous], 2008, Sexually Transmitted Disease Surveillance
[3]  
[Anonymous], 2002, UN TREATM CONFR RAC
[4]   Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users [J].
Arnsten, JH ;
Demas, PA ;
Grant, RW ;
Gourevitch, MN ;
Farzodegan, H ;
Howard, AA ;
Schoenboum, EE .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2002, 17 (05) :377-381
[5]   Role of transport proteins in drug absorption, distribution and excretion [J].
Ayrton, A ;
Morgan, P .
XENOBIOTICA, 2001, 31 (8-9) :469-497
[6]   Substance use and high-risk sex among people with HIV: A comparison across exposure groups [J].
Beckett, M ;
Burnam, A ;
Collins, RL ;
Ranouse, DE ;
Beckman, R .
AIDS AND BEHAVIOR, 2003, 7 (02) :209-219
[7]   The drug efflux-metabolism alliance: biochemical aspects [J].
Benet, LZ ;
Cummins, CL .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 50 :S3-S11
[8]   Factors influencing physicians' judgments of adherence and treatment decisions for patients with HIV disease [J].
Bogart, LM ;
Catz, SL ;
Kelly, JA ;
Benotsch, EG .
MEDICAL DECISION MAKING, 2001, 21 (01) :28-36
[9]  
Brownley KA, 1999, HUM BIOL, V71, P607
[10]   Determinants of enrollment in a preventive HIV vaccine trial [J].
Buchbinder, SP ;
Metch, B ;
Holte, SE ;
Scheer, S ;
Coletti, A ;
Vittinghoff, E .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (01) :604-612